| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.773 | 22.732 | 25.834 | 29.057 | 30.177 | 1.860 | 56.028 | 34.406 | 34.767 | 1.937 |
| Total Income - EUR | 61.871 | 45.124 | 39.087 | 31.966 | 37.217 | 4.754 | 58.170 | 57.560 | 48.959 | 4.009 |
| Total Expenses - EUR | 40.117 | 32.245 | 37.877 | 8.390 | 31.040 | 37.487 | 20.298 | 27.782 | 22.936 | 24.413 |
| Gross Profit/Loss - EUR | 21.754 | 12.879 | 1.210 | 23.577 | 6.177 | -32.733 | 37.872 | 29.778 | 26.023 | -20.404 |
| Net Profit/Loss - EUR | 20.981 | 12.197 | 435 | 22.705 | 5.231 | -32.788 | 36.225 | 28.867 | 22.447 | -20.404 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oriolus Biofarming Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 844.705 | 953.460 | 953.906 | 936.400 | 918.266 | 923.642 | 903.159 | 767.483 | 765.156 | 760.879 |
| Current Assets | 169.267 | 134.479 | 140.484 | 127.746 | 151.107 | 133.891 | 189.363 | 216.039 | 248.631 | 78.000 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 79.203 | 84.823 | 71.304 | 68.985 | 59.903 | 63.382 | 60.023 | 100.187 | 102.179 | 56.058 |
| Cash | 90.064 | 49.656 | 69.180 | 58.761 | 91.203 | 70.509 | 129.340 | 115.852 | 146.452 | 21.942 |
| Shareholders Funds | 58.907 | 70.329 | 69.574 | 91.003 | 94.471 | 59.893 | 94.789 | 123.951 | 146.021 | 124.802 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 955.065 | 1.017.610 | 1.024.816 | 973.143 | 974.901 | 997.641 | 997.733 | 859.571 | 867.765 | 714.077 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6811 - 6811" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Oriolus Biofarming Srl